CURRICULUM VITAE - Stanford University School of Medicine

1985 Principal Investigator. A Murine Model of Graft Versus Host Disease and CMV
Infection. January 1985 - December 1985. Minnesota Medical Foundation
1985 Principal Investigator. Retrovirus Cultures in AIDS.
March 1985 - February 1986. Minnesota Hospital Foundation.
1986 Principal Investigator. Characterization of T-lymphotrophic Retrovirus Infection in
Zimbabwe. July 1986 - June 1987. University of Zimbabwe Research Council.
1992 Principal Investigator. Preparation for AIDS/HIV Vaccine Evaluation in
Zimbabwe.
Sponsor: Division of AIDS, NIAID, R21 AI33868.
Project: 9-30-92 -- 8-31-95
1992 Principal Investigator. Investigation of VaxSyn versus ZDV in asymptomatic HIV
infected individuals. Sponsor: Wyeth-Ayrst Pharmaceuticals.
Project: 6-01-92 -- 5-31-94
1992 Project Director. Virology Core and Developmental, AIDS Clinical Trials Unit.
Sponsor: NIAID, U19 AI27666. (Thomas C. Merigan - principle investigator)
Project: 3-1-92--12-31-95
1994 Principal Investigator. Zimbabwe AIDS Prevention Project / Peer Intervention
HIV transmission. Sponsor:Family Health International, NIAID, NOL AI35173-
129.
Project: 9-01-94--9-29-98
1995 Principal Investigator. Perinatal Transmission of HIV Infection in Zimbabwe.
Sponsor: NIAID, NICHD, DAIDS, R01 AI39013.
Project: 9-30-95--8-31-2000
1996 Principal Investigator. Virology Advanced Technology Laboratories, Adult AIDS
Trials Group. Sponsor: NIAID, U19 AI27666.
Project: 1-1-96 --12-31-99
1999 Prinicpal Investigator, Silver Ion Therapeutics in HIV, Sponsored by Arrow
International.
2000 - Doris Duke Distinguished Clinical Scientist Award. Affordable Feasible Treatment
for HIV infected Women in Southern Africa. Doris Duke Charitable Trust.
3